weight loss pen tirzepatide Shows Superior Over Semaglutide in Phase 3 Trial Tirzepatide Weight Loss Injections &

Initial consultation (30-45 minutes): Complete medical history (current medications, past medical conditions, surgical history, family history) Weight history (highest adult weight, lowest adult weight, previous weight-loss attempts and outcomes) Current diet and exercise patterns Weight-loss goals and timeline expectations Review of contraindications and risk factors Physical exam (blood pressure, heart rate, thyroid exam, abdominal exam) Discussion of expected side effects and management strategies Lab review (if already completed): Confirm BMI calculation Review A1C, lipid panel, metabolic panel Identify weight-related comorbidities Screen for contraindications Treatment plan: Starting dose recommendation (usually 2.5 mg weekly for 4 weeks) Titration schedule (increase by 2.5 mg every 4 weeks as tolerated) Target dose based on goals (5-10 mg for diabetes, 10-15 mg for weight management) Prescription sent to pharmacy (brand-name or compounding pharmacy) Follow-up schedule (typically 4 weeks, then 8-12 weeks) For telehealth visits, the process is identical except the physical exam is limited to what the patient can self-report (blood pressure if they have a home cuff, weight on home scale)

Tirzepatide improves insulin sensitivity even more than semaglutide

R.VenemaK.BlaakE

6 in the non-GLP-1 RA group